Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Evolus, Inc. before investing.

In this article, we go over a few key elements for understanding Evolus, Inc.’s stock price such as:

• Evolus, Inc.’s current stock price and volume
• Why Evolus, Inc.’s stock price changed recently
• Upgrades and downgrades for EOLS from analysts
• EOLS’s stock price momentum as measured by its relative strength

About Evolus, Inc. (EOLS)

Before we jump into Evolus, Inc.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Want to learn more about Evolus, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Evolus, Inc..

Evolus, Inc.’s Stock Price as of Market Close

As of January 15, 2026, 4:00 PM, CST, Evolus, Inc.’s stock price was $5.000.

Evolus, Inc. is 0% from its previous closing price of $5.000.

During the last market session, Evolus, Inc.’s stock traded between $4.740 and $5.130. Currently, there are approximately 64.73 million shares outstanding for Evolus, Inc..

Evolus, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Evolus, Inc. Stock Price History

Evolus, Inc.’s (EOLS) price is currently down 24.81% so far this month.

During the month of January, Evolus, Inc.’s stock price has reached a high of $6.800 and a low of $4.740.

Over the last year, Evolus, Inc. has hit prices as high as $17.120 and as low as $4.740. Year to date, Evolus, Inc.’s stock is down 24.81%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Evolus, Inc. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of January 15, 2026,, no analysts have changed their rating of Evolus, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Evolus, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Evolus, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Evolus, Inc. (EOLS) by visiting AAII Stock Evaluator.

Relative Price Strength of Evolus, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 15, 2026, Evolus, Inc. has a weighted four-quarter relative price strength of -18.80%, which translates to a Momentum Score of 10 and is considered to be Very Weak.

Want to learn more about how Evolus, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Evolus, Inc. Stock Price: Bottom Line

As of January 15, 2026, Evolus, Inc.’s stock price is $5.000, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Evolus, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.